Market Overview

UPDATE: Sterne Agee Maintains PAREXEL International at Underperform Following Guidance

Share:

Sterne Agee reiterated its Underperform rating and $23.50 price target on PAREXEL International (NASDAQ: PRXL).

Sterne Agee noted, "PRXL revised GAAP EPS to $1.32-1.39 (mid: $1.355) from $1.30-1.40 (mid: $1.35). Dilution from the Liquent deal should be about $0.03, so EPS guidance would have gone to $1.32, but instead was maintained at ~$1.35. The incremental $20MM in revenues beyond Liquent is what boosts EPS back to $1.35. None of these clarifications alters our previous estimate changes, but we thought it important to clarify what appears to be quite a bit of confusion among investors."

PAREXEL International closed at $29.51 on Wednesday.

Latest Ratings for PRXL

DateFirmActionFromTo
May 2017UpgradesSellNeutral
May 2017UpgradesHoldOutperform
Feb 2017DowngradesOutperformNeutral

View More Analyst Ratings for PRXL
View the Latest Analyst Ratings

Posted-In: Sterne AgeeAnalyst Color Reiteration Intraday Update Analyst Ratings

 

Related Articles (PRXL)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
CNPMorgan StanleyMaintains27.0
COFMorgan StanleyMaintains105.0
BKMorgan StanleyMaintains51.0
BBTMorgan StanleyMaintains55.0
BACMorgan StanleyMaintains38.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Smith & Wesson Rises After Announcing Share Buyback

UPDATE: Wedbush Reiterates Cardica at Outperform on Key Milestone, Financing Catalyst